» Articles » PMID: 29249216

Pathogen Distribution and Antimicrobial Resistance Among Pediatric Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2011-2014

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

OBJECTIVE To describe pathogen distribution and antimicrobial resistance patterns for healthcare-associated infections (HAIs) reported to the National Healthcare Safety Network (NHSN) from pediatric locations during 2011-2014. METHODS Device-associated infection data were analyzed for central line-associated bloodstream infection (CLABSI), catheter-associated urinary tract infections (CAUTI), ventilator-associated pneumonia (VAP), and surgical site infection (SSI). Pooled mean percentage resistance was calculated for a variety of pathogen-antimicrobial resistance pattern combinations and was stratified by location for device-associated infections (neonatal intensive care units [NICUs], pediatric intensive care units [PICUs], pediatric oncology and pediatric wards) and by surgery type for SSIs. RESULTS From 2011 to 2014, 1,003 hospitals reported 20,390 pediatric HAIs and 22,323 associated pathogens to the NHSN. Among all HAIs, the following pathogens accounted for more than 60% of those reported: Staphylococcus aureus (17%), coagulase-negative staphylococci (17%), Escherichia coli (11%), Klebsiella pneumoniae and/or oxytoca (9%), and Enterococcus faecalis (8%). Among device-associated infections, resistance was generally lower in NICUs than in other locations. For several pathogens, resistance was greater in pediatric wards than in PICUs. The proportion of organisms resistant to carbapenems was low overall but reached approximately 20% for Pseudomonas aeruginosa from CLABSIs and CAUTIs in some locations. Among SSIs, antimicrobial resistance patterns were similar across surgical procedure types for most pathogens. CONCLUSION This report is the first pediatric-specific description of antimicrobial resistance data reported to the NHSN. Reporting of pediatric-specific HAIs and antimicrobial resistance data will help identify priority targets for infection control and antimicrobial stewardship activities in facilities that provide care for children. Infect Control Hosp Epidemiol 2018;39:1-11.

Citing Articles

Utilization of Peripherally Inserted Central Catheters in Neonates Within the Neonatal Intensive Care Unit: A Decadal Single-Center Study.

Fu X, Li Z, Yao L, Haq I, Wang L, Li L Cureus. 2025; 17(1):e77904.

PMID: 39996223 PMC: 11848227. DOI: 10.7759/cureus.77904.


Activity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2020-2022).

Sader H, Mendes R, Arends S, Doyle T, Castanheira M BMC Pulm Med. 2025; 25(1):38.

PMID: 39856702 PMC: 11762134. DOI: 10.1186/s12890-025-03500-8.


Nasal microbiota predictors for methicillin resistant Staphylococcus colonization in critically ill children.

Zani K, Hobeika J, Sun Y, Kohler C, Cherian A, Fields T PLoS One. 2025; 20(1):e0316460.

PMID: 39813207 PMC: 11734933. DOI: 10.1371/journal.pone.0316460.


Enterococcal quorum-controlled protease alters phage infection.

Sheriff E, Salvato F, Andersen S, Chatterjee A, Kleiner M, Duerkop B FEMS Microbes. 2024; 5:xtae022.

PMID: 39156124 PMC: 11328733. DOI: 10.1093/femsmc/xtae022.


Enterococcal quorum-controlled protease alters phage infection.

Sheriff E, Salvato F, Andersen S, Chatterjee A, Kleiner M, Duerkop B bioRxiv. 2024; .

PMID: 38766208 PMC: 11100838. DOI: 10.1101/2024.05.10.593607.


References
1.
Terra R, Plopper C, Waitzberg D, Cukier C, Santoro S, Martins J . Remaining small bowel length: association with catheter sepsis in patients receiving home total parenteral nutrition: evidence of bacterial translocation. World J Surg. 2001; 24(12):1537-41. DOI: 10.1007/s002680010274. View

2.
Stone P, Hedblom E, Murphy D, Miller S . The economic impact of infection control: making the business case for increased infection control resources. Am J Infect Control. 2005; 33(9):542-7. DOI: 10.1016/j.ajic.2005.08.003. View

3.
Perez F, Hujer A, Hujer K, Decker B, Rather P, Bonomo R . Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007; 51(10):3471-84. PMC: 2043292. DOI: 10.1128/AAC.01464-06. View

4.
Hidron A, Edwards J, Patel J, Horan T, Sievert D, Pollock D . NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008; 29(11):996-1011. DOI: 10.1086/591861. View

5.
Stone P . Economic burden of healthcare-associated infections: an American perspective. Expert Rev Pharmacoecon Outcomes Res. 2009; 9(5):417-22. PMC: 2827870. DOI: 10.1586/erp.09.53. View